1 month ago
Johnson & Johnson Settles $5.5B Baby Powder Lawsuits
Johnson & Johnson, a well-known company, has agreed to pay $5.5 billion to settle lawsuits claiming that its baby powder causes cancer.
The lawsuits started in 2009, and the company has always said its product is safe.
The baby powder was discontinued in the US in 2020 and in other countries in 2023.
The settlement covers about 76,000 claims.
Johnson & Johnson says it wants to focus on its main healthcare business.
The company has had mixed results in court, with some wins and some losses.
The settlement needs to be approved by 95% of the claimants.
Johnson & Johnson agrees to a $5.5 billion settlement for lawsuits alleging its talc-based baby powder causes cancer.
The settlement covers approximately 76,000 claims, representing 99.75% of outstanding talc-related cases in the US.
Johnson & Johnson maintains that its products are safe and do not contain asbestos, and that the lawsuits lack scientific merit.
The baby powder was discontinued in the US in 2020 and in other countries in 2023.
The settlement needs to be approved by 95% of the claimants in state or federal courts.
- Who
- Johnson & Johnson and Kenvue Inc
- What
- Settlement of lawsuits alleging that talc-based baby powder causes cancer
- Where
- Headquartered in New Jersey, USA
- When
- Announced on 27th July 2026
- Why
- To resolve thousands of lawsuits and end expensive litigation
Plaintiffs' Claims
Johnson & Johnson's Defense
Product Safety
Plaintiffs' Claims
Plaintiffs allege that Johnson & Johnson's talc-based baby powder contains asbestos and causes ovarian cancer and mesothelioma.
Johnson & Johnson's Defense
Johnson & Johnson maintains that its products are safe, do not contain asbestos, and there is no proof that talc causes cancer.
Legal Strategy
Plaintiffs' Claims
Plaintiffs argue that Johnson & Johnson knew about the risks and lied to the public and regulatory agencies.
Johnson & Johnson's Defense
Johnson & Johnson claims that the lawsuits lack scientific merit and were sustained only by unreliable expert opinions.
Settlement
Plaintiffs' Claims
Plaintiffs see the settlement as a fair resolution to their claims.
Johnson & Johnson's Defense
Johnson & Johnson views the settlement as a way to end expensive litigation and focus on its primary healthcare business.
Key facts
- Company
- Johnson & Johnson
- Product
- Talc-based baby powder
- Allegations
- Causes ovarian cancer and mesothelioma
- Settlement Amount
- $5.5 billion
- Number of Claims
- Approximately 76,000
- Date of Announcement
- 27th July 2026
- Headquarters
- New Jersey, USA
- Subsidiary Involved
- Kenvue Inc
Quotes
Chris Seeger
Lawyer representing approximately 2,500 claimants
“The Court’s order placed plaintiffs in an untenable position of having to present specific causation evidence to maintain their claims that does not exist, and while we are confident the company would have ultimately prevailed with further litigation, this resolution allows the company to put this matter behind it and remain focused on its mission to develop medicines and devices that save lives.”
opindia.com
thestatesman.com
“"After decades of litigation and full vetting of the science in an extensive hearing, plaintiffs effectively conceded their inability to prove specific causation..."”
opindia.com
Sources
Related news
Professor, Five Students Arrested in IGKV Paper Leak
ED arrests key accused in alleged Chhattisgarh exam leak
OpenAI reportedly building donut-shaped ChatGPT smart speaker for homes
Gang Robs Lawyer’s Family of Gold, Cash on Expressway
Bengaluru Engineers Develop Affordable AI PC KEO
Land prices surge to ₹10 crore near Bhogapuram Airport
Colgate India Names Anandani CEO as Narasimhan Takes Regional Role
Neutrogena Faces Boycott Calls After Hayden Panettiere’s Death
Kenvue Launches ORSL and eRZL for Hydration
Paediatrician Criticizes FSSAI Inaction on ORS Ban Post-Delhi HC Order
